samedan logo
 
 
spacer
home > epc > autumn 2002 > what's new in lims?
PUBLICATIONS
European Pharmaceutical Contractor

What's New in LIMS?

In the 21st Century, everyone operating in pharmaceutical or fine chemical QA/QC should be familiar with laboratory information management systems (LIMS). In pharma and contract research particularly, they are ubiquitous. In R&D, the picture is more complex but they are nevertheless commonplace. The LIMS arena has experienced some headline changes recently and a keen awareness of the implications of these could prove invaluable in assessing both the system and the vendor. These can be summarised as follows:

The use of Internet technologies

Compliance with 21 CFR Part 11 and similar regulatory protocols

Both issues are business pressures; the former is, of course, optional and offers process improvements and efficiencies, while the latter is mandatory.

For many laboratories, the choice is now whether to upgrade or replace legacy LIMS, and also whether to harmonise on a single vendor. There is a bewildering choice of LIMS and LIMS vendors. In addition, many other software systems are capable of implementing functionality traditionally viewed as being within LIMS.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By John Dickson, Consultant at Thermo LabSystems

John Dickson joined Thermo LabSystems in 1999. He is a consultant in the Pathfinder global informatics services group, specialising in validation services.

Originally trained as a Medical Laboratory Scientist, John then worked for GlaxoSmithKline for 14 years in quality assurance, responsible for implementation and maintenance of laboratory computer systems. He has a BSc in Computer Science and FIMLS in clinical chemistry.

spacer
John Dickson
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Small Scale Biomanufacturing – clinical trials, cell & gene therapies

18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol

This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >>

 
News and Press Releases

Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement